The Magazine for Sleep Professionals
Friday, July 31, 2026
A pioneering study by sleep researchers at Stanford University, in collaboration with SoundHealth Inc., explores how smartphone facial scans powered by artificial intelligence can analyze facial structures linked to sleep disorders. This innovative approach uses smartphone cameras to assess craniofacial and maxillofacial features, shedding light on potential anatomical contributors to […]
A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest scientific evidence and recommends significant changes in the standard treatment of RLS in adults. Available online as an accepted paper in the […]
A 2024 survey from the American Academy of Sleep Medicine reveals that 51% of Americans have never discussed their sleep with a health professional. The AASM advises that talking about sleep concerns can help doctors identify underlying problems and potentially diagnose a sleep disorder. “Over half (54%) of Americans believe that they don’t […]
LivaNova PLC, a market-leading medical technology company, announced that it met the primary endpoints for its OSPREY randomized controlled trial (RCT), Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation. Together with its safety endpoints, the RCT achieved statistical significance of its primary endpoint responder rates1,2 between the treatment arm […]
Fisher & Paykel Healthcare has announced the launch of F&P Nova MicroTM nasal pillows mask for the treatment of obstructive sleep apnea (OSA) in the USA. Weighing less than 1.4 ounces (40 grams), the new compact mask features minimal, easy-adjusting headgear and a soft MicroPillowsTM cushion that nestles gently within […]
Avadel Pharmaceuticals plc , a biopharmaceutical company focused on transforming medicines to transform lives, announced that yesterday, the U.S. District Court for the District of Columbia (“Court”) ruled in favor of the Food and Drug Administration (“FDA”) in a suit brought by Jazz Pharmaceuticals Inc. (“Jazz”) under the Administrative Procedure […]
EnsoData and HappyHealth, manufacturers of the Happy Ring, announce a partnership to meet the growing demand for simple, clinical-grade nightly sleep monitoring in the home. Happy Health’s platform, Happy Sleep, allows patients to directly receive an FDA-approved sleep test powered by EnsoSleep PPG, see a board-certified sleep doctor, and begin […]
Sleep Specialists, LLC (DBA 2Z Medical) announces that Zzoma is now covered by a growing number of leading health insurance providers. This expanded coverage significantly increases access to this innovative, mask-free treatment option for individuals with positional OSA across the United States. Zzoma is an FDA-cleared positional therapy device indicated […]
Avadel Pharmaceuticals plc announced today that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for LUMRYZ for the treatment of cataplexy or EDS in patients 7 years of age and older with narcolepsy. “This approval represents an important milestone for the narcolepsy community, […]
